Downstream Processing

News in brief

ABL Europe equips viral vector plant with Sartorius single-use tech

16-Mar-2018 By Staff Reporter

Both upstream and downstream systems provided by Sartorius Stedim Biotech have been installed in ABL’s facility in Strasbourg, France.

Up to down: BIA and Nuvonis to address ‘last frontier in bioprocessing’

15-Mar-2018 By Dan Stanton

BIA Separations has teamed with Nuvonis Technologies to help vaccine and cell therapy developers tackle the transition from upstream to downstream processing.

Cryoport ups cold chain presence on regenerative med potential

07-Mar-2018 By Dan Stanton

Cryoport will open two global centres and has inked a deal with McKesson to support the growth in demand for cell and gene therapy logistics.

Sartorius talks M&A as it looks to more than double revenues by 2025

27-Feb-2018 By Dan Stanton

Sartorius expects its Bioprocess Solutions Division to make €2.8bn ($3.4bn) annually by 2025 through a mix of organic growth and technology bolt-ons.

Concurrent purification approach could cut ADC manufacture by 25%, ADC Bio

16-Feb-2018 By Dan Stanton

ADC Bio has developed a concurrent conjugation and antibody purification process, not reliant on Protein A capture resin.

Correction

Repligen adding former Motorola plant in MA to filtration footprint

13-Feb-2018 By Dan Stanton

Repligen has leased a 64,000 square-foot facility in Massachusetts to where it will transfer production of its TangenX filtration products .

Cryoport wins TiGenix logistics contract and braces for CAR T roll out

09-Feb-2018 By Staff Reporter

Cryoport will provide cold chain logistics to TiGenix as it conducts phase Ib/IIa allogeneic adipose‐derived stem cells for the treatment of sepsis.

Operations reshuffle behind job cuts at Sanofi Genzyme

09-Feb-2018 By Flora Southey

Outsourcing and operational changes at the Allston Landing facility influenced Sanofi’s decision to layoff workers in Massachusetts, US.

Vetter securing customer commitments ahead of groundbreaking at US site

06-Feb-2018 By Melissa Fassbender

Vetter is talking with customers to create a “stable financial plan” that will justify the manufacturer’s previously announced $320m investment for a new facility, which is not expected to break ground before 2022.

Waters launches LC platform-neutral bioseparations system

06-Feb-2018 By Staff Reporter

Waters Corporation says its latest bioseparations system can drive cost-savings through reduced solvent volumes and decreased run times.

Celltrion slammed with US FDA warning at biosimilar site

02-Feb-2018 By Dan Stanton

Celltrion says supply of Pfizer’s Inflectra is secure, despite receiving a US FDA warning letter at its biosimilar production plant in Korea.

Pall the ‘stand-out’ in Danaher’s life sciences Q4 results

31-Jan-2018 By Staff Reporter

Pall Corporation reported its best quarterly growth since its acquisition by Danaher in 2015.

Sanofi expanding Fabrazyme plant in MA

31-Jan-2018 By Dan Stanton

Sanofi will expand its Framingham, Massachusetts biomanufacturing facility by 14,820 square-foot to support its product portfolio.

Paragon expansion to address ‘deficit in gene therapy CDMO capacity’

24-Jan-2018 By Dan Stanton

The CDMO says it is building a 150,000 square-foot biomanufacturing facility in Maryland in preparation for a double-digit growth in the gene therapy space.

Cellular Biomedicine Group adopts GE Healthcare tech for CAR-T therapy production

19-Jan-2018 By Gareth Macdonald

Cellular Biomedicine Group Inc (CBMG) has selected GE Healthcare’s FlexFactory technology for its CAR-T therapy production facility in Shanghai, China.